Uncategorized

Aviceda Therapeutics Appoints Ophthalmology Innovator and Industry Leader Dr. Emmett T. Cunningham, Jr. to Board of Directors

by Business Wire • 2025/04/09 • 0 Comments

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aviceda Therapeutics Appoints Ophthalmology Innovator and Industry Leader Dr. Emmett T. Cunningham, Jr. to Board of Directors

← NexThera vient de terminer le premier recrutement de patients dans le cadre d’un essai clinique aux États-Unis portant sur le NT-101, une goutte oculaire visant à traiter la DMLA humide

Modest Effects of Valacyclovir in Herpes Zoster Eye Disease →